Sio Capital Management, LLC Kura Oncology, Inc. Transaction History

Sio Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $2.79 Million - $4.47 Million	-228,318 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $93,368 - $131,514	6,055 Added 2.72%	228,318 $4.28 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $183,313 - $262,704	8,792 Added 4.12%	222,263 $4.63 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $2.01 Million - $3.18 Million	81,188 Added 61.37%	213,471 $6.04 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $2.93 Million - $4.2 Million	101,000 Added 322.86%	132,283 $4.32 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $185,820 - $349,296	-11,400 Reduced 26.71%	31,283 $959,000
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $339,329 - $802,867	42,683 New	42,683 $696,000
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $1.98 Million - $2.44 Million	-144,411 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $6.18 Million - $10.2 Million	-582,847 Reduced 80.14%	144,411 $2.03 Million
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $1.84 Million - $2.41 Million	-110,346 Reduced 13.17%	727,258 $12.7 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $2.67 Million - $3.39 Million	180,193 Added 27.41%	837,604 $15.2 Million
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $3.85 Million - $6.21 Million	265,384 Added 67.7%	657,411 $12.3 Million
Q4 2017 Feb 14, 2018	BUY	$13.5 - $16.65 $1.57 Million - $1.94 Million	116,296 Added 42.18%	392,027 $6 Million
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $1.67 Million - $4.12 Million	275,731	275,731 $4.12 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.06B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.